Vimta Labs per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹18.01₹17.40₹30.28₹17.52₹21.37
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹17.79₹17.20₹29.86₹17.26₹20.96
₹102.28₹102.28₹170.38₹142.67₹126.79
₹96.02₹91.18₹154.70₹141.13₹142.39
—₹32.94₹42.55₹26.64₹39.09
₹10.60₹10.60₹6.80−₹7.37₹16.60
—₹1.00₹1.99₹2.00₹2.00
4.54.52.22.22.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

VIMTALABS₹519.80

Vimta Labs Limited

· Pharma & Health
₹ CrorePeersSUVENTAKEMcap ₹2,322 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS21.3717.5230.2817.4018.01
Diluted EPS20.9617.2629.8617.2017.79
Book Value per Share126.79142.67170.38102.28102.28
Revenue per Share142.39141.13154.7091.1896.02
Cash Flow per Share39.0926.6442.5532.94—
Free Cash Flow per Share16.60-7.376.8010.6010.60
Dividends per Share2.002.001.991.00—
Shares Outstanding (cr)2.22.22.24.54.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.